Graf Akcie GSK (Glaxosmithkline plc). Diskuze k akciím GSK. Aktuální informace GSK.

Základní informace o společnosti Glaxosmithkline plc (Akcie GSK)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 96.2B
Hodnota podniku (EV) 128.67B
Tržby 0
EBITDA 0
Zisk 0
Růst v tržbách Q/Q 5.74 %
Růst v tržbách Y/Y N/A %
P/E (Cena vůči ziskům) 16.60
Forward P/E N/A
EV/Sales 2.85
EV/EBITDA 7.24
EV/EBIT 11.97
PEG 3.36
Price/Sales 2.15
P/FCF 20.61
Price/Book 4.85
Účetní hodnota na akcii 8.04
Hotovost na akcii 3.73
FCF vůči ceně 6.67 %
Počet zaměstnanců 0
Tržba na zaměstnance N/A
Profit margin 16.86 %
Operating margin 23.51 %
Gross margin 68.06 %
EBIT margin 23.79 %
EBITDA margin 39.31 %
EPS - Zisk na akcii 2.35
EPS - Kvartální růst 71.74 %
EPS - Očekávaný růst příští rok -14.00 %
Return on assets 5.55 %
Return on equity 29.69 %
ROIC 10.58 %
ROCE 14.11 %
Dluhy/Equity 4.09
Čistý dluh/EBITDA 6.13
Current ratio 0.82
Quick Ratio 0.53
Volatilita 1.26
Beta 0.54
RSI 50.54
Cílová cena analytiků 63
Známka akcie (dle analytiků) 2.04
Insider ownership 0.01 %
Institutional ownership 12.64 %
Počet akcií 2.516B
Procento shortovaných akcií 0.00 %
Short ratio 4.81 %
Dividenda 2.18
Procentuální dividenda 5.63 %
Dividenda/Zisk 92.81 %
Obchodovaná od 1978
Země United Kingdom

Finanční výsledky akcie GSK

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$43,783.12$43,100.48$41,139.87$38,903.72$37,797.96$36,578.27
Cost Of Goods Sold$15,027.94$15,147.86$13,669.69$13,328.77$12,590.74$13,536.24
Gross Profit$28,755.18$27,952.62$27,470.18$25,574.95$25,207.22$23,042.03
Research And Development Expenses$6,545.832$5,832.879$5,196.376$5,768.669$4,917.028$5,443.24
SG&A Expenses$14,709.5$14,559.21$13,234.54$12,465.27$12,693.74$14,115.73
Other Operating Income Or Expenses$2,493.528$1,327.976$-1,720.557$-2,073.679$-4,075.387$12,299.28
Operating Expenses$33,789.75$34,211.98$33,821.16$33,636.39$34,276.89$20,795.93
Operating Income$9,993.371$8,888.504$7,318.707$5,267.328$3,521.066$15,782.34
Total Non-Operating Income/Expense$-1,046.46$-944.906$-911.669$-724.306$-893.143$311.916
Pre-Tax Income$8,946.912$7,943.595$6,407.04$4,543.02$2,627.927$16,094.25
Income Taxes$744.72$1,216.886$1,006.439$1,747.613$1,188.598$3,293.466
Income After Taxes$8,202.192$6,726.709$5,400.601$2,795.407$1,439.329$12,800.79
Other Income------
Income From Continuous Operations$8,202.192$6,726.709$5,400.601$2,795.407$1,439.329$12,800.79
Income From Discontinued Operations------
Net Income$7,381.716$5,931.201$4,835.98$1,974.442$1,236.034$12,877.24
EBITDA$10,794.59$11,868.79$9,796.096$7,744.402$5,925.369$18,274.61
EBIT$9,993.371$8,888.504$7,318.707$5,267.328$3,521.066$15,782.34
Basic Shares Outstanding2,4882,4742,4572,4432,4302,416
Shares Outstanding2,4882,5082,4862,4712,4552,444
Basic EPS$2.97$2.40$1.97$0.81$0.51$5.33
EPS - Earnings Per Share$2.93$2.36$1.95$0.80$0.50$5.27
# 2020 2019 2018 2017 2016 2015
Current Ratio0.81040.75260.59870.87951.23631.104
Long-term Debt / Capital0.56240.84660.80350.74710.63320.7624
Debt/Equity Ratio1.66197.0984.8983.7861.87343.8055
Gross Margin64.854566.772765.739166.689462.993868.1692
Operating Margin20.622817.789813.53949.315543.146814.2876
EBIT Margin20.622817.789813.53949.315543.146814.2876
EBITDA Margin27.537523.811719.906615.676449.960323.094
Pre-Tax Profit Margin18.430415.573811.67766.952643.999512.901
Net Profit Margin13.761311.7555.07523.270135.204612.3055
Asset Turnover0.42360.53080.53540.4720.44760.5659
Inventory Turnover Ratio1.99481.87021.86111.82091.87721.7308
Receiveable Turnover4.52224.63334.82364.46084.12824.8556
Days Sales In Receivables80.712278.776875.669881.823788.41675.1703
ROE - Return On Equity28.6975110.185262.166821.398494.300584.891
Return On Tangible Equity-22.7461-20.9431-10.9507-5.3696-64.6187-58.9507
ROA - Return On Assets6.61056.96793.8471.797515.664410.3078
ROI - Return On Investment12.558716.898512.21775.411734.592220.1676
Book Value Per Share8.70881.82241.67392.50595.0639-
Operating Cash Flow Per Share-0.43920.91340.02161.9802-1.8997-1.0876
Free Cash Flow Per Share-0.40330.94120.162.0007-1.9131-1.166

Porovnání s konkurencí: Akcie GSK

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
GSK 16.60 3.36 N/A % -14.00 % 29.69 % 4.85 16.86 %

Nedávné obchody insiderů: Akcie GSK

Jméno Obchod Cena Objem

Diskuze k akciím GSK